DJIA 17,390.52 195.10 1.13%
NASDAQ 4,630.74 64.60 1.41%
S&P 500 2,018.05 23.40 1.17%
market minute promo

4.83 -0.03 (-0.62%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PGNX $4.83 -0.62%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.00
Previous Close $4.86
Daily Range $4.78 - $5.00
52-Week Range $3.10 - $7.45
Market Cap $336.0M
P/E Ratio -7.97
Dividend (Yield) $0.00 (0.0%)
Volume 478,672
Average Daily Volume 878,529
Current FY EPS -$0.01

Sector

Healthcare

Industry

Drugs

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary Rss Feed

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

Looking For My Next Triple In Biotech

Phase 2 Data for Progenics' 1404 Imaging Agent Presented at EANM Congress

Progenics Gets $40M Milestone on FDA Approval of Relistor - Analyst Blog

Progenics Receives $40M Milestone Following FDA Approval of RELISTOR For OIC Patients With Chronic N

Progenics Receives $40M Milestone Following FDA Approval of RELISTOR For OIC Patients With Chronic Non-Cancer Pain

Progenics/Salix's Relistor Label Expanded in the U.S. - Analyst Blog

Progenics: Inexpensive Way To Win Big 3 Potential Ways

Progenics: Inexpensive Way To Win Big Three Potential Ways

Sector Update: Health Care Shares Flat in Pre-Market Trade

Sector Update: Health Care

Progenics' Azedra Found Positive in Phase II Follow-Up Data - Analyst Blog

Progenics' Azedra Found Positive in Phase II Follow-Up Data - Analyst Blog

See More PGNX News...

PGNX's Top Competitors

PGNX $4.83 (-0.62%)
Current stock: PGNX
AMGN $162.18 (0.37%)
Current stock: AMGN
BIIB $321.08 (0.02%)
Current stock: BIIB
CELG $107.09 (0.14%)
Current stock: CELG